
Doctor Dan Zhu
Peking University Third Hospital, Beijing (China)
Follow
Contributor content
Presentation
Oral HRS-5346, a novel small molecule lipoprotein(a) inhibitor, in adults at high cardiovascular risk with elevated lipoprotein(a): a phase 2, randomized, double-blind study
Presentation


